Daryl W. Borley

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Correction: Novel in vitro booster vaccination to rapidly generate antigen-specific human monoclonal antibodies.

Correction: Novel in vitro booster vaccination to rapidly generate antigen-specific human monoclonal antibodies.

Journal: The Journal of experimental medicine
Published: August 23, 2017

Novel in vitro booster vaccination to rapidly generate antigen-specific human monoclonal antibodies.

Novel in vitro booster vaccination to rapidly generate antigen-specific human monoclonal antibodies.

Journal: The Journal of experimental medicine
Published: April 05, 2017

Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.

Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.

Journal: PloS one
Published: June 10, 2016

Tracking the Antigenic Evolution of Foot-and-Mouth Disease Virus.

Tracking the Antigenic Evolution of Foot-and-Mouth Disease Virus.

Journal: PloS one
Published: November 17, 2015

Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.

Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.

Journal: PloS one
Published: August 24, 2015

A Tool for Investigating Asthma and COPD Exacerbations: A Newly Manufactured and Well Characterised GMP Wild-Type Human Rhinovirus for Use in the Human Viral Challenge Model.

A Tool for Investigating Asthma and COPD Exacerbations: A Newly Manufactured and Well Characterised GMP Wild-Type Human Rhinovirus for Use in the Human Viral Challenge Model.

Journal: PloS one
Published: August 20, 2015

Use of qualitative integrative cycler PCR (qicPCR) to identify optimal therapeutic dosing time-points in a Respiratory Syncytial Virus Human Viral Challenge Model (hVCM).

Use of qualitative integrative cycler PCR (qicPCR) to identify optimal therapeutic dosing time-points in a Respiratory Syncytial Virus Human Viral Challenge Model (hVCM).

Journal: Journal of virological methods
Published: April 28, 2015

Evaluation and use of in-silico structure-based epitope prediction with foot-and-mouth disease virus.

Evaluation and use of in-silico structure-based epitope prediction with foot-and-mouth disease virus.

Journal: PloS one
Published: August 22, 2012
Showing 1-8 of 8

Last Updated: 09/26/2026